Clinical Trial

Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia

Name: Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia — clinical trial record (NCT06223607)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The use of clopidogrel as part of DAPT will be associated with lower bleeding rates compared to ticagrelor in patients with chronic thrombocytopenia requiring Percutaneous intervention (PCI )with Drug Eluting Stent (DES) or Bare Metal Stint(BMS).

Trial Details

NCT Number	NCT06223607
Lead Sponsor	Methodist Health System
Conditions	Baseline Thrombocytopenia
Enrollment	300 participants
Start Date	2022-08-22
Primary Completion	2026-12-28 (estimated)
Study Completion	2027-12-22 (estimated)
Updated on ClinicalTrials.gov	2026-06-10